Malahat Movahedian
Rheumatology · San Diego, CANPI 1386022945
Payments from drug & device makers
Across 272 payments — averaging $21.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$846
- Johnson & Johnson$748
- UCB, Inc.$660
- GSK$590
- Mallinckrodt Hospital Products Inc.$286
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,88899%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 57 | $1,306 |
| AbbVie | 50 | $846 |
| Johnson & Johnson(2 entities) | 35 | $748 |
| UCB, Inc. | 32 | $660 |
| GSK | 22 | $590 |
| Mallinckrodt Hospital Products Inc. | 12 | $286 |
| Novartis | 12 | $281 |
| Radius Health, Inc. | 6 | $155 |
| E.r. Squibb & Sons, L.L.C. | 7 | $145 |
| Lilly USA, LLC | 6 | $139 |
| AstraZeneca | 2 | $134 |
| Aurinia Pharma U.S., Inc. | 5 | $119 |
| Boehringer Ingelheim | 5 | $117 |
| Pfizer | 5 | $97 |
| Neurocrine Biosciences, Inc. | 2 | $56 |
| Fresenius Kabi USA, LLC | 2 | $45 |
| Actelion Pharmaceuticals US, Inc. | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Oxford Immunotec USA Inc | 1 | $23 |
| Antares Pharma, Inc. | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Bioventus LLC | 1 | $21 |
| Sanofi | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Zimmer Biomet | 1 | $18 |
| Cala Health, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,968 in reported general payments places this provider in the 60th percentile of 808 rheumatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 46 | $344,012 |
| ProliaDenosumab | 116 | $206,491 |
| Humira(Cf) PenAdalimumab | 23 | $190,051 |
| Teriparatide | 53 | $179,210 |
| OrenciaAbatacept/Maltose | 14 | $57,620 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 23 | $57,500 |
| Hydroxychloroquine Sulfate | 253 | $9,266 |
| MethotrexateMethotrexate Sodium | 161 | $3,183 |
| Colchicine | 32 | $2,993 |
| Leflunomide | 43 | $2,907 |
| Pilocarpine Hcl | 25 | $1,953 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 35 | $1,780 |
| Duloxetine Hcl | 85 | $1,656 |
| Mycophenolate Mofetil | 20 | $1,360 |
| Gabapentin | 122 | $1,288 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia, Evenity (2 Syringes) | $1,306 | $263,990139 claims |
| E.r. Squibb & Sons, L.L.C.Orencia | $145 | $57,62014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 808 rheumatology providers in California.
Other rheumatology in San Diego
- Ara DikranianSan Diego$2.6M
- Arthur MabaquiaoSan Diego$1.6M
- Kenneth KalunianSan Diego$1.4M
- Samy MetyasCovina$12.9M
- Christine ThaiHuntington Beach$8.5M
- Tien-I SuWhittier$8.4M
- Eric LeeUpland$6.9M
- Orrin TroumSanta Monica$6.9M
- Shirley PangFullerton$5.7M
- William RobinsonStanford$5.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.